Curis
CRIS
#11170
Rank
$2.08 M
Marketcap
$0.86
Share price
3.72%
Change (1 day)
-48.20%
Change (1 year)

Curis (CRIS) - Total assets

Total assets on the balance sheet as of June 2026 : $18.97 Million USD

According to Curis's latest financial reports the company's total assets are $18.97 Million USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Curis - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$19.96 M-51.62%
2024-12-31$41.26 M-46.6%
2023-12-31$77.28 M-29%
2022-12-31$0.10 B-32.93%
2021-12-31$0.16 B-20.58%
2020-12-31$0.20 B482.1%
2019-12-31$35.1 M-6.04%
2018-12-31$37.36 M-49.37%
2017-12-31$73.79 M27.78%
2016-12-31$57.75 M-39.19%
2015-12-31$94.96 M51.67%
2014-12-31$62.61 M-22.31%
2013-12-31$80.59 M15.51%
2012-12-31$69.76 M44.81%
2011-12-31$48.18 M-4.87%
2010-12-31$50.64 M40.31%
2009-12-31$36.09 M-9.71%
2008-12-31$39.98 M-25.71%
2007-12-31$53.81 M2.96%
2006-12-31$52.26 M-14.19%
2005-12-31$60.91 M-9.53%
2004-12-31$67.33 M20.8%
2003-12-31$55.73 M-10.74%
2002-12-31$62.44 M-56.86%
2001-12-31$0.14 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
$201.13 B 1,060,158.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$87.63 B 461,860.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
$0.10 B 467.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$2.49 B 13,048.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.78 B 4,024.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
$21.35 M 12.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$1.11 B 5,787.19%๐Ÿ‡บ๐Ÿ‡ธ USA